New hope for advanced colon cancer patients who've run out of options
Disease control
Not yet recruiting
This early study tests a new drug, SHR-3821, combined with fruquintinib in 12 people with advanced colorectal cancer that has not responded to at least two standard treatments. The goal is to see if the combination is safe and can shrink tumors or slow the disease. This is not a …
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC